<DOC>
	<DOCNO>NCT01531517</DOCNO>
	<brief_summary>Clinical Trial Phase III-b Study Sponsor : European Egyptian Pharmaceutical Industries Sample Size : 120 patient ( 60 per arm ) Study Population : Patients Diabetic foot ulcer stage proper surgical treatment - need . Those patient recruit patient attend Diabetic foot Center Faculty Medicine - Alexandria University outpatient clinic Faculty Medicine , Cairo University . Recruitment Period : 9 month Dose application : thick layer 2-3 mm apply dress dress applied ulcer . Endpoints : Complete heal ulcer OR 5 month application ointment whichever come first</brief_summary>
	<brief_title>Study Efficacy PedyPhar® Ointment Diabetic Foot Ulcers</brief_title>
	<detailed_description>Study Design : This open label randomize non-placebo study 120 subject randomly allocate treatment PedyPhar ointment Panthenol ointment diabetic foot ulcer . Treatment ointment precede appropriate surgical treatment remove necrotic tissue indicate surgeon foot ulcer Wagner stag 3-5 . Also , diabetic status control part study . Ointment either arm apply ulcer maximum 5 month till complete heal whichever happen first . Patients visit study center every 2 week assessment ulcer do patient give ointment dress enough 2 week . Blood flow affect leg assess besides kidney function complete blood picture besides kidney function . Diabetic status monitor every month glycosylated hemoglobin do every 3 month Study Duration : 12 month Study Agent/Intervention Description : PEDYPHAR® new patent local ointment compose natural ( Royal Jelly ) ( Dexpanthenol ) innovate , enrich alkaline ointment base . Dose application : thick layer 2-3 mm apply dress dress applied ulcer .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Propolis</mesh_term>
	<mesh_term>Pantothenic Acid</mesh_term>
	<criteria>Adult diabetic foot syndrome subject 18 year age sex All stage diabetic foot syndrome include Wagner stage 5 Midfoot gangrene appropriate surgical treatment . Patients suffer type 1 type 2 diabetes mellitus diabetic foot syndrome . Stable metabolic pharmacological control recruitment trial period . Adequate perfusion lower limb measure HHD confirm APSV . Nondiabetic foot ulceration ( traumatic , thermal ulceration etc ) Diabetic foot syndrome grade 5 Wagner 's scale hind foot gangrene . Any pathological state disease affect development outcomes diabetic foot syndrome liver cell failure renal failure Severe limb ischemia ( clinical assessment HHD ) unless revascularized . Presence slough sequestrum unless debrided . Hemoglobin le 8 g/dl unless correct . Those receive NSAIDs , steroids antimitotic drug . Septicemia patient require urgent amputation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Pedyphar</keyword>
	<keyword>Ointment</keyword>
	<keyword>Healing</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Foot Ulcer</keyword>
</DOC>